Effects of nebivolol and ivabradine on the left ventricular diastolic function in patients (pts) with COPD and stable angina Source: International Congress 2014 – COPD markers Year: 2014
Safety of nebivolol and bisoprolol in patients (pts) with COPD and stable angina. Source: International Congress 2018 – Cardiovascular morbidities in COPD Year: 2018
Τhe influence of pulmonary disease on ventricular diastolic dysfunction in COPD patients Source: Eur Respir J 2003; 22: Suppl. 45, 539s Year: 2003
Clinical characteristics of COPD patients suspected of left ventricular diastolic dysfunction Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies Year: 2019
Effects of nebivolol and ivabradine on myocardial ischemia in patients (pts) with COPD and stable angina during 24-hour ambulatory Holter ECG monitoring. Source: International Congress 2017 – Extrapulmonary comorbidities in COPD Year: 2017
Left ventricular diastolic function in patients with high altitude-induced pulmonary hypertension Source: Eur Respir J 2002; 20: Suppl. 38, 98s Year: 2002
Right ventricular (RV) diastolic function in patients with pulmonary hypertension (PH) due to chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2002; 20: Suppl. 38, 26s Year: 2002
Right ventricular diastolic function in patients with COPD and heart failure, depending on endothelial function Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation Year: 2013
Effect of long-term therapy with short-acting β2 -agonist on left ventricle systolic function in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2004; 24: Suppl. 48, 14s Year: 2004
Right ventricular global strain and right ventricular dyssynchrony can predict success to pulmonary vasodilators therapy in PH patients Source: Annual Congress 2012 - Pulmonary circulation: clinical diagnosis, treatment, end-points and animal models Year: 2012
Characterization of dynamic left ventricular systolic and diastolic function in patients with obstructive sleep apnea syndrome with preserved left ventricular ejection fraction Source: International Congress 2018 – Pulmonary hypertension: right ventricle function, haemodynamics and exercise Year: 2018
Diagnosis of left ventricular diastolic dysfunction using echocardiography in COPD patients with pulmonary arterial hypertension Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment Year: 2009
Left ventricular hipertrophy (LVH) and diastolic dysfunction (DD) in obstructive sleep apnea (SAHS) patients Source: Annual Congress 2009 - Cardiovascular complications in obstructive sleep apnoea Year: 2009
The evaluation of right and left ventricular dysfunction in COPD patients with pulmonary hypertension Source: Eur Respir J 2001; 18: Suppl. 33, 250s Year: 2001
Right and left ventricular dysfunction in patients with COPD and heart failure Source: Eur Respir J 2007; 30: Suppl. 51, 706s Year: 2007
The role of prostanoids for stress induced left ventricular diastolic dysfunction in non-severe COPD patients Source: International Congress 2019 – Cardiovascular comorbidities in COPD Year: 2019
Is there benefit from proactive case-detection of left ventricular systolic dysfunction (LVSD) using BNP in patients with advanced COPD? Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases Year: 2016
Pulmonary hypertension, right and left ventricular dysfunction in patients with COPD Source: Eur Respir J 2006; 28: Suppl. 50, 404s Year: 2006
Non-invasive parameters can predict out of proportion pulmonary hypertension (PH) in conjunction with heart failure and preserved systolic function (HFPSF) in patients with moderate to severe PH Source: Annual Congress 2010 - Pulmonary hypertension updates Year: 2010
Prognostic value of right ventricular systolic dysfunction in patients with chronic obstructive pulmonary disease after ST-segment elevation myocardial infarction (STEMI). Source: Virtual Congress 2020 – Air pollution and comorbidities Year: 2020